Network pharmacology study on the mechanism of traditional Chinese medicine for upper respiratory tract infection.

Traditional Chinese medicine (TCM) is a multi-component and multi-target agent and could treat complex diseases in a holistic way, especially infection diseases. However, the underlying pharmacology remains unclear. Fortunately, network pharmacology by integrating system biology and polypharmacology provides a strategy to address this issue. In this work, Reduning Injection (RDN), a well-used TCM treatment in the clinic for upper respiratory tract infections (URTIs), was investigated to interpret the molecular mechanism and predict new clinical directions by integrating molecular docking, network analysis and cell-based assays. 32 active ingredients and 38 potential targets were identified. In vitro experiments confirmed the bioactivities of the compounds against lipopolysaccharide (LPS)-stimulated PGE2 and NO production in RAW264.7 cells. Moreover, network analysis showed that RDN could not only inhibit viral replication but also alleviate the sickness symptoms of URTIs through directly targeting the key proteins in the respiratory viral life cycle and indirectly regulating host immune systems. In addition, other clinical applications of RDN such as neoplasms, cardiovascular diseases and immune system diseases were predicted on the basis of the relationships between targets and diseases.

[1]  Yang Song,et al.  Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery , 2011, Nucleic Acids Res..

[2]  N. Meanwell.  Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety. , 2011, Chemical research in toxicology.

[3]  M. Nahata,et al.  Complementary and alternative medicine for upper-respiratory-tract infection in children. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[4]  Gary D Bader,et al.  A travel guide to Cytoscape plugins , 2012, Nature Methods.

[5]  Hwangseo Park,et al.  Critical assessment of the automated AutoDock as a new docking tool for virtual screening , 2006, Proteins.

[6]  Y. Kuan,et al.  Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and inhibition of MAPK and NFκB pathways in mice with endotoxin-induced acute lung injury. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  Mark E. J. Newman.  A measure of betweenness centrality based on random walks , 2005, Soc. Networks.

[8]  W. Xiao,et al.  A randomized controlled clinical study on treatment of hand, foot and mouth disease in children with Reduning injection. , 2013, Chinese medical journal.

[9]  R. Eccles,et al.  Understanding the symptoms of the common cold and influenza , 2005, The Lancet Infectious Diseases.

[10]  G. Du,et al.  Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. , 2008, Planta medica.

[11]  D. Kitts,et al.  Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells , 2004, Molecular and Cellular Biochemistry.

[12]  Makoto Murakami,et al.  Prostaglandin E synthase: a novel drug target for inflammation and cancer. , 2006, Current pharmaceutical design.

[13]  L. Furlong.  Human diseases through the lens of network biology. , 2013, Trends in genetics : TIG.

[14]  Hao Zhang,et al.  MEK1-ERKs signal cascade is required for the replication of Enterovirus 71 (EV71). , 2012, Antiviral research.

[15]  Xu Xiaojie,et al.  Study on Mechanism of the Reduning Injection on the Influenza Virus Using Network Pharmacology Method , 2013 .

[16]  J. Schwarze,et al.  Respiratory Viral Infections in Infants: Causes, Clinical Symptoms, Virology, and Immunology , 2010, Clinical Microbiology Reviews.

[17]  Xiaofei Shang,et al.  Lonicera japonica Thunb.: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine , 2011, Journal of Ethnopharmacology.

[18]  Effect of lipophilicity modulation on inhibition of human rhinovirus capsid binders. , 2011, Bioorganic & medicinal chemistry letters.

[19]  J. Winter,et al.  Tackling upper respiratory tract infections. , 2010, The Practitioner.

[20]  Samiul Hasan,et al.  Network analysis has diverse roles in drug discovery. , 2012, Drug discovery today.

[21]  D. Galas,et al.  Diseases as network perturbations. , 2010, Current opinion in biotechnology.

[22]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[23]  T. Fahey,et al.  Systematic review of the treatment of upper respiratory tract infection , 1998, Archives of disease in childhood.

[24]  Yan-jing Li,et al.  Direct analysis in real time ionization/quadrupole time-of-flight tandem mass spectrometry for rapid identification of iridoid glycosides and caffeoylquinic acids in Re Du Ning Injections , 2013 .

[25]  D. Proud.  Upper airway viral infections , 2007, Pulmonary Pharmacology & Therapeutics.

[26]  A. Fendrick,et al.  The economic burden of non-influenza-related viral respiratory tract infection in the United States. , 2003, Archives of internal medicine.

[27]  Jianfeng Pei,et al.  Understanding molecular mechanisms of traditional Chinese medicine for the treatment of influenza viruses infection by computational approaches. , 2013, Molecular bioSystems.

[28]  Shun Xu,et al.  Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus , 2011, Comput. Biol. Chem..

[29]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[30]  L. Sautebin.  Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy. , 2000, Fitoterapia.

[31]  Ravi Iyengar,et al.  Network analyses in systems pharmacology , 2009, Bioinform..

[32]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[33]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[34]  Yao-lan Li,et al.  Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin. , 2005, Antiviral research.

[35]  Shao Li,et al.  A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study. , 2014, Molecular bioSystems.

[36]  L. Bielory,et al.  Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. , 2009, The Journal of allergy and clinical immunology.

[37]  Qing Zhang,et al.  The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema , 2004, Nucleic Acids Res..

[38]  Jaques Reifman,et al.  DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0 , 2008, Chemistry Central journal.

[39]  O. Planz,et al.  Combination of MEK inhibitors and oseltamivir leads to synergistic antiviral effects after influenza A virus infection in vitro. , 2013, Antiviral research.

[40]  J. Gostner,et al.  Pathway-focused bioassays and transcriptome analysis contribute to a better activity monitoring of complex herbal remedies , 2013, BMC Genomics.

[41]  Ting Li,et al.  Traditional Chinese herbal medicine as a source of molecules with antiviral activity , 2012, Antiviral Research.

[42]  A. Monto,et al.  Epidemiology of viral respiratory infections , 2002, The American Journal of Medicine.

[43]  Ling-Ling Yang,et al.  Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. , 2001, Biochemical pharmacology.

[44]  Gisbert Schneider,et al.  Scaffold diversity of natural products: inspiration for combinatorial library design. , 2008, Natural product reports.

[45]  Luonan Chen,et al.  Network-based drug repositioning. , 2013, Molecular bioSystems.

[46]  S. Yedgar,et al.  Control of phospholipase A2 activities for the treatment of inflammatory conditions. , 2006, Biochimica et biophysica acta.

[47]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[48]  H. Xiang,et al.  Geniposide inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. , 2013, International immunopharmacology.

[49]  Hong Chen,et al.  Anti-inflammatory and immunomodulatory mechanisms of artemisinin on contact hypersensitivity. , 2012, International immunopharmacology.

[50]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[51]  Li Li,et al.  Molecular network and chemical fragment-based characteristics of medicinal herbs with cold and hot properties from Chinese medicine. , 2013, Journal of ethnopharmacology.

[52]  G. Boivin,et al.  Treatment of respiratory virus infections , 2006, Antiviral Research.

[53]  L. Stitt,et al.  Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial , 2005, Canadian Medical Association Journal.

[54]  I. Merfort,et al.  Anti-Oxidant, Anti-Inflammatory and Anti-Allergic Activities of Luteolin , 2008, Planta medica.

[55]  D. Nieman,et al.  Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial , 2010, Pharmacological Research.

[56]  Qian Li,et al.  A Network-Based Multi-Target Computational Estimation Scheme for Anticoagulant Activities of Compounds , 2011, PloS one.

[57]  Shao Li,et al.  Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula , 2009 .

[58]  E. De Clercq,et al.  Molecular strategies to inhibit the replication of RNA viruses , 2008, Antiviral Research.

[59]  Lirong Chen,et al.  Use of Natural Products as Chemical Library for Drug Discovery and Network Pharmacology , 2013, PloS one.

[60]  N. Hacohen,et al.  A Physical and Regulatory Map of Host-Influenza Interactions Reveals Pathways in H1N1 Infection , 2009, Cell.

[61]  Complementary and Integrative Treatments , 2013, Otolaryngologic Clinics of North America.